| Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation I Galve-Roperh, C Sánchez, ML Cortés, TG del Pulgar, M Izquierdo, ... Nature medicine 6 (3), 313-319, 2000 | 843 | 2000 |
| Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor C Sánchez, ML de Ceballos, TG del Pulgar, D Rueda, C Corbacho, ... Cancer research 61 (15), 5784-5789, 2001 | 564 | 2001 |
| Towards the use of cannabinoids as antitumour agents G Velasco, C Sánchez, M Guzmán Nature Reviews Cancer 12 (6), 436-444, 2012 | 517 | 2012 |
| A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme M Guzman, MJ Duarte, C Blazquez, J Ravina, MC Rosa, I Galve-Roperh, ... British journal of cancer 95 (2), 197-203, 2006 | 456 | 2006 |
| Δ9‐Tetrahydrocannabinol induces apoptosis in C6 glioma cells C Sánchez, I Galve-Roperh, C Canova, P Brachet, M Guzmán FEBS letters 436 (1), 6-10, 1998 | 349 | 1998 |
| Anticancer mechanisms of cannabinoids G Velasco, C Sánchez, M Guzmán Current Oncology 23 (2), S23, 2016 | 298 | 2016 |
| Control of the cell survival/death decision by cannabinoids M Guzmán, C Sánchez, I Galve-Roperh Journal of molecular medicine 78 (11), 613-625, 2001 | 294 | 2001 |
| Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation MM Caffarel, D Sarrió, J Palacios, M Guzmán, C Sánchez Cancer research 66 (13), 6615-6621, 2006 | 289 | 2006 |
| Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary … C Sánchez, I Galve-Roperh, D Rueda, M Guzmán Molecular Pharmacology 54 (5), 834-843, 1998 | 249 | 1998 |
| Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition MM Caffarel, C Andradas, E Mira, E Pérez-Gómez, C Cerutti, ... Molecular cancer 9 (1), 1-11, 2010 | 238 | 2010 |
| De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis TG del PULGAR, G Velasco, C Sánchez, H Amador, M Guzmán Biochemical Journal 363 (1), 183-188, 2002 | 238 | 2002 |
| The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK C Andradas, MM Caffarel, E Perez-Gomez, M Salazar, M Lorente, ... Oncogene 30 (2), 245-252, 2011 | 227 | 2011 |
| Cannabinoids and cell fate M Guzmán, C Sánchez, I Galve-Roperh Pharmacology & therapeutics 95 (2), 175-184, 2002 | 221 | 2002 |
| Ceramide: a new second messenger of cannabinoid action M Guzmán, I Galve-Roperh, C Sánchez Trends in pharmacological sciences 22 (1), 19-22, 2001 | 186 | 2001 |
| Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 CM Henstridge, NAB Balenga, J Kargl, C Andradas, AJ Brown, A Irving, ... Molecular Endocrinology 25 (11), 1835-1848, 2011 | 178 | 2011 |
| Cannabinoids: a new hope for breast cancer therapy? MM Caffarel, C Andradas, E Pérez-Gómez, M Guzmán, C Sánchez Cancer treatment reviews 38 (7), 911-918, 2012 | 153 | 2012 |
| The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan C Sánchez, D Rueda, B Ségui, I Galve-Roperh, T Levade, M Guzmán Molecular Pharmacology 59 (5), 955-959, 2001 | 147 | 2001 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ... Journal of Biological Chemistry 289 (32), 21960-21972, 2014 | 139 | 2014 |
| Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study E Murillo-Rodriguez, C Blanco-Centurion, C Sanchez, P Daniele, ... Sleep 26 (8), 943-947, 2003 | 128 | 2003 |
| Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel, ... Journal of the National Cancer Institute 107 (6), djv077, 2015 | 122 | 2015 |
